January 2013 FDA Recall Daytrana by Noven Pharmaceuticals, Inc.
D-312-2013 - Defective Delivery System

This Class II drug recall was voluntarily initiated by Noven Pharmaceuticals, Inc. on January 31, 2013 for the product Daytrana. The FDA reported the reason for recall as defective delivery system. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-312-2013

Reason for Recall
Defective Delivery System: Out of Specification (OOS) results for the z-statistic value, which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration, were obtained.
Initiated
01-31-2013
Reported
05-08-2013
Quantity
335,910 patches

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Noven Pharmaceuticals, Inc.
Nationwide and Puerto Rico.
Daytrana (methylphenidate) transdermal system patch, Delivers 10 mg over 9 hours (1.1 mg/hr), 1 patch per pouch, packaged in 30-count patches per box, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, By Noven Pharmaceuticals, Inc., Miami, FL 33186; NDC 68968-5552-3.

Batch or Lot Expiration Information

Lot# 59824, Exp 04/13